Aleta Biotherapeutics is an immuno-oncology company founded in 2015 and based in Natick, Massachusetts. The company develops drugs that transform cellular therapeutics, allowing a broad spectrum of tumor types to be targeted, including currently intractable solid tumors. By doing so, healthcare professionals can treat their patients in an effective and efficient manner. Aleta Biotherapeutics' focus on immuno-oncology drugs shows promise in treating intractable cancerous tumors.